KrausMD, FlemingMD, VonderheideMH. The spleen as a diagnostic specimen: a review of 10 years, experience at two tertiary care institutions. Cancer.2001; 91: 2001–2009.
FalkS, StutteHJ, FrizzeraG. A novel splenic vascular lesion demonstrating histiocytic differentiation. Am J Surg Pathol.1991; 15: 1023–1033.
4.
AbbottRM, LevyAD, AguileraNS, GorospeL, ThompsonWM. From the archives of the AFIP: primary vascular neoplasms of the spleen: radiologic-pathologic correlation. Radiographica.2004; 24: 1137–1163.
5.
BiscegliaM, SickelJZ, GiangasperoF, GomesV, AminiM, MichalM. Littoral cell angioma of the spleen: an additional report of four cases with emphasis on the association with visceral organ cancers. Tumori.1998; 84: 595–599.
6.
Ben-IzhakO, BejarJ, Ben-EliezerS, VlodavskyE. Splenic littoral cell haemangioendothelioma: a new low-grade variant of malignant littoral cell tumour. Histopathology.2001; 39: 469–475.
KrausMD, DehnerLP. Benign vascular neoplasms of the spleen with myoid and angioendotheliomatous features. Histopathology.1999; 35: 328–336.
9.
KrishnanJ, FrizzeraG. Two splenic lesions in need of clarification: hamartoma and inflammatory pseudotumor. Semin Diagn Pathol.2003; 20: 94–104.
10.
MartelM, CheukW, LombardiL, Lifschitz-MercerB, ChanJK, RosaiJ. Sclerosing angiomatoid nodular transformation (SANT): report of 25 cases of a distinctive benign splenic lesion. Am J Surg Pathol.2004; 28: 1268–1279.
11.
KuoTT, ChenTC, LeeLY. Sclerosing angiomatoid nodular transformation of the spleen (SANT): clinicopathological study of 10 cases with or without abdominal disseminated calcifying fibrous tumors, and the presence of a significant number of IgG4+ plasma cells. Pathol Int.2009; 59: 844–850.
12.
AwamlehAA, Perez-OrdonezB. Sclerosing angiomatoid nodular transformation of the spleen. Arch Pathol Lab Med.2007; 131: 974–978.
13.
ChiuA, CzaderM, ChengL, WangM, KnowlesDM, Al-AhmadieH, OraziA. Clonal X chromosome inactivation suggests that splenic cord capillary hemangioma and myoid angioendothelioma are true neoplasms and not subtypes of splenic hamartoma. Lab Invest2009; 89(Suppl, 1): 259A (Abstract 1180).
14.
KashiwagiS, KumasakaT, BunseiN. Detection of Epstein-Barr virus-encoded small RNA-expressed myofibro-blasts and IgG4-producing plasma cells in sclerosing angio-matoid nodular transformation of the spleen. Virchows Arch.2008; 453: 275–282.
15.
NagaiY, HayamaN, KishimotoT. Predominance of IgG4+ plasma cells and CD68 positivity in sclerosing angi-omatoid nodular transformation (SANT). Histopathology.2008; 53: 495–498.
16.
DieboldJ, Le TourneauA, MarmeyB. Is sclerosing angiomatoid nodular transformation (SANT) of the splenic red pulp identical to inflammatory pseudotumour? Report of 16 cases. Histopathology.2008; 53: 299–310.
17.
FalkS, KrishnanJ, MeisJM. Primary angiosarcoma of the spleen. A clinicopathologic study of 40 cases. Am J Surg Pathol.1993; 17: 959–970.
18.
NeuhauserTS, DerringerGA, ThompsonLD. Splenic angiosarcoma: a clinicopathologic and immunophenotypic study of 28 cases. Mod Pathol.2000; 13: 978–987.
19.
ArberDA, StricklerJG, ChenYY, WeissLM. Splenic vascular tumors: a histologic, immunophenotypic, and virologic study. Am J Surg Pathol.1997; 21: 827–835.
20.
RossoR, GianelliU, ChanJK. Further evidence supporting the sinus lining cell nature of splenic littoral cell angiosarcoma. Am J Surg Pathol.1996; 20: 1531.
21.
SusterS. Epithelioid and spindle-cell hemangioendothelioma of the spleen. Report of a distinctive splenic vascular neoplasm of childhood. Am J Surg Pathol.1992; 16: 785–792.
22.
AkatsuT, KameyamaK, TanabeM, EndoT, KitajimaM. Epstein-Barr virus-positive inflammatory pseudotumor of the spleen with concomitant rectal cancer: a case report and review of the literature. Dig Dis Sci.2007; 52: 2806–2812.
23.
DalalBI, GreenbergH, QuinonezGE, GoughJC. Inflammatory pseudotumor of the spleen. Morphological, radiological, immunophenotypic, and ultrastructural features. Arch Pathol Lab Med.1991; 115: 1062–1064.
24.
KutokJL, PinkusGS, DorfmanDM, FletcherCD. Inflammatory pseudotumor of lymph node and spleen: an entity biologically distinct from inflammatory myofibroblastic tumor. Hum Pathol.2001; 32: 1382–1387.
25.
LewisJT, GaffneyRL, CaseyMB, FarrellMA, MoriceWG, MaconWR. Inflammatory pseudotumor of the spleen associated with a clonal Epstein-Barr virus genome. Case report and review of the literature. Am J Clin Pathol.2003; 120: 56–61
26.
MoranCA, SusterS, AbbondanzoSL. Inflammatory pseudotumor of lymph nodes: a study of 25 cases with emphasis on morphological heterogeneity. Hum Pathol.1997; 28: 332–338.
27.
OzkaraSK, GurbuzY, ErcinC, MuezzinogluB, TurkmenM. Inflammatory pseudotumor of the spleen. Virchows Arch.2001; 438: 629–631.
28.
RosenbaumL, FekrazadMH, RabinowitzI, VasefMA. Epstein-Barr virus-associated inflammatory pseudotumor of the spleen: report of two cases and review of the literature. J Hematopathol.2009; 2: 127–131.
29.
ChenHW, LaiEC, HuangXJ. Inflammatory myofi-broblastic tumours of the spleen and liver. Asian J Surg.2008; 31: 25–28.
30.
HermanTE, ShackelfordGD, TernbergJL, DehnerLP. Inflammatory myofibroblastic tumor of the spleen: report of a case in an adolescent. Pediatr Radiol.1994; 24: 280–282.
31.
NeuhauserTS, DerringerGA, ThompsonLD. Splenic inflammatory myofibroblastic tumor (inflammatory pseudotumor): a clinicopathologic and immunophenotypic study of 12 cases. Arch Pathol Lab Med.2001; 125: 379–385.
32.
CheukW, ChanJK, ShekTW. Inflammatory pseudotu-mor-like follicular dendritic cell tumor: a distinctive low-grade malignant intra-abdominal neoplasm with consistent Epstein-Barr virus association. Am J Surg Pathol.2001; 25: 721–731.
